NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read The GALAXY Study has provided compelling data that highlights the predictive value of circulating tumor DNA (ctDNA) status in colorectal…
SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer Breast Cancer 2 Mins Read The FDA has recently approved Kisqali (ribociclib) in combination with a non-steroidal aromatase inhibitor (NSAI) for the treatment of early-stage…
Genetic Testing Cancer, Practice Changing? – Dr. Erica Giblin, MD Breast Cancer 3 Mins Read By: Dr. Erica Giblin, MD, from Ascension Medical Group Conference: ASBrS Genetic Testing Cancer In recent years, the field of…
